Insider Trades41 trades
| Date↓ | Side | Ticker↕ | Insider↕ | Role↕ | Shares↕ | Price↕ | Mkt Cap↕ | 52W High↕ | 52W Low↕ | Value↕ | % Chg↕ | Rule↕ | AI View↕ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 2, 2026 | Sell | RGNX | Steve Pakola | Chief Medical Officer | 4,322 | $10.75 | $511.3M | -38.91% | +81.30% | $46.5K | +0.00% | 10b5-1 | Stalk |
| Jun 29, 2026 | Sell | RGNX | Steve Pakola | Chief Medical Officer | 93,058 | $10.50 | $511.3M | -38.91% | +81.30% | $977.4K | -2.57% | 10b5-1 | Stalk |
| May 11, 2026 | Sell | RGNX | Steve Pakola | Chief Medical Officer | 15,309 | $11.02 | $511.3M | -38.91% | +81.30% | $168.7K | -6.17% | 10b5-1 | Stalk |
| Mar 10, 2026 | Sell | RGNX | Steve Pakola | Chief Medical Officer | 5,124 | $10.35 | $511.3M | -38.91% | +81.30% | $53.0K | -2.02% | 10b5-1 | Stalk |
| Feb 1, 2026 | Sell | RGNX | Patrick J. Christmas | Chief Strategy & Legal Officer | 4,700 | $11.16 | $511.3M | -38.91% | +81.30% | $52.5K | -2.18% | — | Stalk |
| Feb 1, 2026 | Sell | RGNX | Steve Pakola | Chief Medical Officer | 5,267 | $11.16 | $511.3M | -38.91% | +81.30% | $58.8K | -2.04% | — | Stalk |
| Jan 2, 2026 | Sell | RGNX | Craig Malzahn | Chief Technology Officer | 1,238 | $14.40 | $511.3M | -38.91% | +81.30% | $17.8K | -7.04% | — | Stalk |
| Jan 2, 2026 | Sell | RGNX | Patrick J. Christmas | Chief Strategy & Legal Officer | 9,793 | $14.40 | $511.3M | -38.91% | +81.30% | $141.0K | -6.47% | — | Stalk |
| Jan 2, 2026 | Sell | RGNX | Steve Pakola | Chief Medical Officer | 18,247 | $14.40 | $511.3M | -38.91% | +81.30% | $262.8K | -8.66% | — | Stalk |
| Jan 2, 2026 | Sell | RGNX | Curran Simpson | Chief Executive Officer | 18,559 | $14.40 | $511.3M | -38.91% | +81.30% | $267.2K | -8.59% | — | Stalk |
| Dec 31, 2025 | Sell | RGNX | Curran Simpson | Chief Executive Officer | 9,222 | $12.00 | $511.3M | -38.91% | +81.30% | $110.7K | -0.43% | — | Stalk |
| Oct 9, 2025 | Sell | RGNX | Curran Simpson | Chief Executive Officer | 20,811 | $12.62 | $511.3M | -38.91% | +81.30% | $262.6K | -8.78% | 10b5-1 | Stalk |
| Sep 29, 2025 | Sell | RGNX | Curran Simpson | Chief Executive Officer | 7,624 | $10.03 | $511.3M | -38.91% | +81.30% | $76.5K | -3.12% | 10b5-1 | Stalk |
| Sep 10, 2025 | Sell | RGNX | Curran Simpson | Chief Executive Officer | 7,734 | $10.02 | $511.3M | -38.91% | +81.30% | $77.5K | -3.07% | 10b5-1 | Stalk |
| Sep 1, 2025 | Sell | RGNX | Craig Malzahn | Chief Technology Officer | 234 | $8.93 | $511.3M | -38.91% | +81.30% | $2.1K | -1.31% | — | Stalk |
| Sep 1, 2025 | Sell | RGNX | Mitchell Chan | Chief Financial Officer | 4,901 | $8.93 | $511.3M | -38.91% | +81.30% | $43.8K | -8.33% | — | Stalk |
| Aug 1, 2025 | Sell | RGNX | Patrick J. Christmas | Chief Strategy & Legal Officer | 4,699 | $8.19 | $511.3M | -38.91% | +81.30% | $38.5K | -3.01% | — | Stalk |
| Jul 1, 2025 | Sell | RGNX | Curran Simpson | Chief Executive Officer | 4,701 | $8.23 | $511.3M | -38.91% | +81.30% | $38.7K | -1.83% | — | Stalk |
| Feb 1, 2025 | Sell | RGNX | Patrick J. Christmas | Chief Legal Officer | 4,700 | $8.07 | $511.3M | -38.91% | +81.30% | $37.9K | -2.92% | — | Stalk |
| Feb 1, 2025 | Sell | RGNX | Steve Pakola | Chief Medical Officer | 5,263 | $8.07 | $511.3M | -38.91% | +81.30% | $42.5K | -2.44% | — | Stalk |
| Feb 1, 2025 | Sell | RGNX | Olivier Danos | Chief Scientific Officer | 5,452 | $8.07 | $511.3M | -38.91% | +81.30% | $44.0K | -2.35% | — | Stalk |
| Jan 2, 2025 | Sell | RGNX | Patrick J. Christmas | Chief Legal Officer | 11,395 | $7.73 | $511.3M | -38.91% | +81.30% | $88.1K | -2.88% | — | Stalk |
| Jan 2, 2025 | Sell | RGNX | Curran Simpson | Chief Executive Officer | 11,917 | $7.73 | $511.3M | -38.91% | +81.30% | $92.1K | -1.84% | — | Stalk |
| Jan 2, 2025 | Sell | RGNX | Olivier Danos | Chief Scientific Officer | 12,630 | $7.73 | $511.3M | -38.91% | +81.30% | $97.6K | -4.50% | — | Stalk |
| Jan 2, 2025 | Sell | RGNX | Steve Pakola | Chief Medical Officer | 13,891 | $7.73 | $511.3M | -38.91% | +81.30% | $107.4K | -5.16% | — | Stalk |
| Aug 1, 2024 | Sell | RGNX | Curran Simpson | Chief Executive Officer | 100 | $15.00 | $511.3M | -38.91% | +81.30% | $1.5K | -0.06% | 10b5-1 | Stalk |
| Jul 29, 2024 | Sell | RGNX | Curran Simpson | Chief Executive Officer | 9,648 | $15.04 | $511.3M | -38.91% | +81.30% | $145.1K | -5.37% | 10b5-1 | Stalk |
| Jun 28, 2024 | Buy | RGNX | Olivier Danos | Chief Scientific Officer | 1,363 | $9.95 | $511.3M | -38.91% | +81.30% | $13.6K | +1.09% | — | Stalk |
| May 14, 2024 | Sell | RGNX | Kenneth T. Mills | President and CEO | 30,000 | $9.79 | $511.3M | -38.91% | +81.30% | $293.6K | +0.00% | 10b5-1 | Stalk |
| Apr 15, 2024 | Sell | RGNX | Kenneth T. Mills | President and CEO | 30,000 | $10.98 | $511.3M | -38.91% | +81.30% | $329.3K | +0.00% | 10b5-1 | Stalk |
| Mar 19, 2024 | Buy | RGNX | Vittal Vasista | Chief Financial Officer | 20,041 | $3.76 | $511.3M | -38.91% | +81.30% | $75.4K | +8.85% | — | Stalk |
| Mar 14, 2024 | Sell | RGNX | Kenneth T. Mills | President and CEO | 30,000 | $12.81 | $511.3M | -38.91% | +81.30% | $384.3K | +0.00% | 10b5-1 | Stalk |
| Mar 5, 2024 | Sell | RGNX | Steve Pakola | Chief Medical Officer | 25,756 | $25.31 | $511.3M | -38.91% | +81.30% | $651.8K | +0.00% | 10b5-1 | Stalk |
| Feb 14, 2024 | Sell | RGNX | Kenneth T. Mills | President and CEO | 30,000 | $10.26 | $511.3M | -38.91% | +81.30% | $307.7K | +0.00% | 10b5-1 | Stalk |
| Jan 16, 2024 | Sell | RGNX | Kenneth T. Mills | President and CEO | 90,000 | $9.47 | $511.3M | -38.91% | +81.30% | $852.2K | +0.00% | 10b5-1 | Stalk |
| Jan 2, 2024 | Sell | RGNX | Vittal Vasista | Chief Financial Officer | 4,534 | $17.95 | $511.3M | -38.91% | +81.30% | $81.4K | -1.56% | — | Stalk |
| Jan 2, 2024 | Sell | RGNX | Patrick J. Christmas | Chief Legal Officer | 7,893 | $17.95 | $511.3M | -38.91% | +81.30% | $141.7K | -5.48% | — | Stalk |
| Jan 2, 2024 | Sell | RGNX | Curran Simpson | Chief Oper. & Tech. Officer | 8,120 | $17.95 | $511.3M | -38.91% | +81.30% | $145.8K | -5.27% | — | Stalk |
| Jan 2, 2024 | Sell | RGNX | Kenneth T. Mills | President and CEO | 11,357 | $17.95 | $511.3M | -38.91% | +81.30% | $203.9K | -1.72% | — | Stalk |
| Jan 2, 2024 | Sell | RGNX | Steve Pakola | Chief Medical Officer | 27,622 | $17.60 | $511.3M | -38.91% | +81.30% | $486.2K | -9.93% | 10b5-1 | Stalk |
| Dec 19, 2023 | Sell | RGNX | Kenneth T. Mills | President and CEO | 90,000 | $11.67 | $511.3M | -38.91% | +81.30% | $1.1M | +0.00% | 10b5-1 | Stalk |